Postoperative Same Day Closure of Giant Macular Hole With Silicone Oil
NCT ID: NCT06915948
Last Updated: 2025-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2021-05-01
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Retinal Re-surgeries in Silicone Oil Filled Eyes
NCT06583798
Duration of Silicone Oil Tamponade on Foveal and Parafoveal Thickness in Rhegmatogenous Retinal Detachment
NCT05817630
Optical Coherence Tomography Angiography Characteristics of Patients With Surgically Closed Full-thickness Idiopathic Macular Holes < 600 μm With Air Versus 10% SF6 Tamponade
NCT05223205
Efficacy and Safety of Myopic Macular Hole Closure Surgery Without Endotamponade Agent
NCT07129798
Macular Micro Vascular Changes Following Macular Hole Repair : Optical Coherence Tomography Angiography Study
NCT06233500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Basic demographic profile which includes name, age, gender , address was noted .
Structured questionnaire was used to collect information about the presence of any systemic risk factors like diabetes mellitus, hypertension, any prior retinal surgery and high myopia .
Preoperatively , all subjects will be tested for BCVA , intraocular pressure measurement, slit lamp bio-microscopy of anterior segment and indirect non contact bio-microscopy of the fundus with 20D lens will be documented .
Using spectral domain optical coherence tomography diagnosis of macular hole was confirmed and hole form factor and diameter hole index calculated based on the findings in optical coherence tomography.
Patients with stage 3 and 4 macular holes of size \>700 u who underwent pars plana vitrectomy, ILM peeling and silicone oil tamponade were shortlisted.
Patients follow up was done on day 1, 2 weeks and 1 month post silicone oil removal .
For each follow up , BCVA with silicon oil and intraocular pressure was measured and indirect noncontact bio-microscopy examination of the macula was examined. Assessment of macula was done using OCT on day 1, 2 weeks and 1 month post silicone oil removal .
In all patients the anatomical closure of macular hole was assessed on day 1, 2 weeks and 1 month post silicone oil removal .
Statistical methods
* The information recorded on the data collection forms were uploaded in an excel sheet and data were analyzed using IBM SPSS version 20.
* To obtain the characteristic of categorical variables, frequency and percentage were applied.
* To obtain the characteristic of numerical variables, mean and standard deviation were used.
* Chi square test/ Fisher's exact test was used to find association between HFF, DHI, gender with hole closure type of closure.
* Students t test and Man Whitney U test were performed to compare the average values of numerical parameters such as age, BCVA with hole closure, type of closure, HFF, DHI.
* Paired t test was used to compare the pre-Op and Final BCVA. P-value \<0.05 was consideredto denote statistical significance.
* ANOVA was used wherever we had to compare numerical data/means between 3 groups of type of hole closure- open vs type I vs type II closure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Macular Hole Surgery
Pars Plana Vitrectomy with ILM peeling with silicone oil tamponade
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who give a valid informed consent
* Patients who underwent surgery
Exclusion Criteria
* Patients with history of ocular trauma
* Patients with history of any macular surgery
* Rhegmatogenous retinal detachment associated with macular hole
* Patients having vision loss due to other ocular comorbidities- glaucoma , macular pathology or vitreous hemorrhage.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahalia Foundation Eye Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Saurav Mahajan
Principal Investigator, Clinical Professor Adjunct
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rajkumar Maheshwari, MS
Role: PRINCIPAL_INVESTIGATOR
Ahalia Foundation Eye Hospital
Amrutha S, DNB
Role: PRINCIPAL_INVESTIGATOR
Ahalia Foundation Eye Hospital
Saurav Mahajan, MS
Role: PRINCIPAL_INVESTIGATOR
Ahalia Foundation Eye Hospital
Sajeev C Jacob, MS
Role: STUDY_CHAIR
Ahalia Foundation Eye Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahaliafoundation Eye Hospital
Palakkad, Kerala, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1312-4425
Identifier Type: OTHER
Identifier Source: secondary_id
202103.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.